🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary Objective: To evaluate for each influenza strain the non-inferiori...
Status
Completed
Location
Multiple Locations
Start Date
2006-10
Trial ID
NCT00391391
This is a Phase Ib study in healthy adults (18-70 years) to evaluate the sa...
Status
Completed
Location
Stanford University School of Medicine
Start Date
2012-08
Trial ID
NCT01676402
Treatments Being Tested
The purpose of this study is to evaluate the possibility that giving an inc...
Status
Completed
Location
Emory Children's Center - Pediatric Infectious Diseases
Start Date
2010-10
Trial ID
NCT01164553
Treatments Being Tested
This study will evaluate the safety and immunogenicity in healthy children ...
Status
Completed
Location
Centro de Atención e Investigación Medica - CAIMED
Start Date
2010-09
Trial ID
NCT01209780
Treatments Being Tested
This study evaluates whether priming influenza naive infants, age six to 23...
Status
Completed
Location
Vaccine Evaluation Center, BC Children's Hospital
Start Date
2018-11-01
Trial ID
NCT03669627
Treatments Being Tested
In this exploratory study, investigators will be looking at immune response...
Status
Completed
Location
Multiple Locations
Start Date
2013-10
Trial ID
NCT03020537
Treatments Being Tested
The purpose of this research study is to find out if giving the smaller dos...
Status
Completed
Location
Saint Louis University
Start Date
2005-11
Trial ID
NCT00253734
Treatments Being Tested
In solid organ transplant (SOT) the receipt of influenza vaccine in an infl...
Status
Completed
Location
University of Minnesota
Start Date
2023-09-11
Trial ID
NCT05663463
Treatments Being Tested
The purpose of this study is to evaluate Immunogenicity and Safety of a Hig...
Status
Completed
Location
CenExel CNS- Site Number : 8400005
Start Date
2024-11-04
Trial ID
NCT06641180
The aim of this study is to evaluate the safety and immunogenicity of Fluzo...
Status
Completed
Location
Multiple Locations
Start Date
2012-09
Trial ID
NCT01691339